Ontology highlight
ABSTRACT: Background
This review comprehensively assesses all prospective trials on anti-cancer vaccines for common hematological malignancies by analyzing trial designs, endpoints, and whether these endpoints are met across these trials.Methods
We included onco prospective clinical trials involving therapeutic anti-cancer vaccines for hematological malignancies published up to May 2025. We excluded retrospective cohort studies, case reports, non-research opinion publications, and studies not related to hematological malignancies. Information sources: Embase, MEDLINE, Web of Science Core Collection, and ClinicalTrials.gov. All the included RCTs were assessed for bias using the Cochrane Handbook for Systematic Review of Interventions, version 6.2 and Cochrane risk-of-bias tool. Result
SUBMITTER: Shah D
PROVIDER: S-EPMC12305733 | biostudies-literature | 2025 Aug
REPOSITORIES: biostudies-literature